DHG Pharmaceutical JSC (DHG) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.063x

Based on the latest financial reports, DHG Pharmaceutical JSC (DHG) has a cash flow conversion efficiency ratio of 0.063x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫214.23 Billion ≈ $8.14 Million USD) by net assets (₫3.42 Trillion ≈ $129.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DHG company net worth for the company's overall valuation and market capitalisation.

DHG Pharmaceutical JSC - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how DHG Pharmaceutical JSC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

DHG Pharmaceutical JSC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DHG Pharmaceutical JSC ranked by their cash flow conversion efficiency. Explore how high is DHG Pharmaceutical JSC's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shandong Tongda Island New Materials Co Ltd SHE:300321	-0.010x
Viromed Medical AG DU:Q11	-0.038x
Zhejiang Wandekai Fluid Equipment Technology Co. Ltd. A SHE:301309	N/A
Chun Yuan Steel Industry Co Ltd TW:2010	0.019x
Oriental Kopi Holdings Berhad KLSE:0338	0.052x
Yibin Paper Industry Co Ltd SHG:600793	0.088x
Deutsche Rohstoff AG XETRA:DR0	0.070x
EMX Royalty Corp V:EMX	0.059x

Annual Cash Flow Conversion Efficiency for DHG Pharmaceutical JSC (2019–2025)

The table below shows the annual cash flow conversion efficiency of DHG Pharmaceutical JSC from 2019 to 2025. View DHG stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₫4.18 Trillion ≈ $158.91 Million	₫1.21 Trillion ≈ $46.09 Million	0.290x	-9.87%
2024-12-31	₫4.09 Trillion ≈ $155.58 Million	₫1.32 Trillion ≈ $50.06 Million	0.322x	+457.94%
2023-12-31	₫4.85 Trillion ≈ $184.38 Million	₫279.88 Billion ≈ $10.63 Million	0.058x	-72.54%
2022-12-31	₫4.29 Trillion ≈ $163.05 Million	₫901.28 Billion ≈ $34.24 Million	0.210x	+76.07%
2021-12-31	₫3.79 Trillion ≈ $144.12 Million	₫452.44 Billion ≈ $17.19 Million	0.119x	-48.49%
2020-12-31	₫3.57 Trillion ≈ $135.56 Million	₫826.17 Billion ≈ $31.39 Million	0.232x	-6.70%
2019-12-31	₫3.38 Trillion ≈ $128.33 Million	₫838.24 Billion ≈ $31.85 Million	0.248x	--

About DHG Pharmaceutical JSC

VN:DHG Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$449.56 Million

₫11.83 Trillion VND

Market Cap Rank

#12982 Global

#58 in Vietnam

Share Price

₫90500.00

Change (1 day)

+0.00%

52-Week Range

₫90000.00 - ₫108100.00

All Time High

₫130801.51